The Canadian Liver Cancer market size stood at around USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
Liver cancer occurs when abnormal cells within the liver grow in an uncontrolled way. There are two main types of liver cancer which are named after the part of the liver cancer first develops in, they are Hepatocellular carcinoma, & Cholangiocarcinoma. Liver cancer can either be primary or metastatic. Metastatic liver cancer is much more common than primary liver cancer in Canada. In 2020, an estimated 3,100 Canadians were diagnosed with liver cancer, 1,450 Canadians died from it, among these 2,300 men were diagnosed and 1,150 died from it, 810 women were diagnosed and 290 died from it.
The market size drivers for the growth of liver cancer diagnostics are expected to propel by the rise in the number of alcohol addiction, & growing R&D investments and reimbursement policies. Deaths from liver cancer in Canada have doubled over the past 25 years. And to make matters worse, there’s an epidemic of liver cancer on the horizon if action isn’t taken soon. Factors such as the rising incidence of liver cancer and growing research activities for developing novel treatments coupled with increasing government funding for cancer treatment research are driving the liver cancer treatment market.